Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
UTAH MEDICAL PRODUCTS INC roe for the quarter ending 2026-06-30 was 8.59%, a 19.55% decline year-over-year.
UTAH MEDICAL PRODUCTS INC roe for the quarter ending 2026-03-31 was 9.01%, a 18.60% decline year-over-year.
UTAH MEDICAL PRODUCTS INC roe for the quarter ending 2025-12-31 was 9.46%, a 19.91% decline year-over-year.
UTAH MEDICAL PRODUCTS INC roe for the quarter ending 2025-09-30 was 9.83%, a 20.00% decline year-over-year.
UTAH MEDICAL PRODUCTS INC roe for fiscal 2025 was 9.46%, a 19.91% decline from fiscal 2024.
UTAH MEDICAL PRODUCTS INC roe for fiscal 2024 was 11.81%, a 8.87% decline from fiscal 2023.
UTAH MEDICAL PRODUCTS INC roe for fiscal 2023 was 12.96%, a 10.08% decline from fiscal 2022.
UTAH MEDICAL PRODUCTS INC roe for fiscal 2022 was 14.42%, a 4.46% increase from fiscal 2021.